Growth Metrics

Zymeworks (ZYME) Equity Ratio (2021 - 2025)

Zymeworks' Equity Ratio history spans 3 years, with the latest figure at 0.76 for Q3 2023.

  • For Q3 2023, Equity Ratio rose 27.4% year-over-year to 0.76; the TTM value through Sep 2023 reached 0.76, up 27.4%, while the annual FY2022 figure was 0.76, 18.71% up from the prior year.
  • Equity Ratio for Q3 2023 was 0.76 at Zymeworks, up from 0.75 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.79 in Q1 2023 and bottomed at 0.6 in Q3 2022.
  • The 3-year median for Equity Ratio is 0.75 (2023), against an average of 0.72.
  • The largest annual shift saw Equity Ratio increased 18.71% in 2022 before it rose 27.4% in 2023.
  • A 3-year view of Equity Ratio shows it stood at 0.64 in 2021, then rose by 18.71% to 0.76 in 2022, then grew by 0.37% to 0.76 in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Equity Ratio are 0.76 (Q3 2023), 0.75 (Q2 2023), and 0.79 (Q1 2023).